top of page
Browse by category
Search
Some plastic surgeons are treating obesity as a cosmetic issue rather than a chronic disease
Researchers from the College of Public Health, Temple University, Philadelphia, PA, have warned how some plastic surgeons are promoting...
MBS achieves greater weight loss with lower ongoing cost vs GLP-1s
Metabolic bariatric surgery (MBS) achieves greater weight loss and lower ongoing cost compared to the glucagon-like peptide-1 receptor...
Journal watch 17/9/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Lilly’s oral GLP-1 orforglipron shows meaningful weight loss and cardiometabolic improvements
Results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron, an investigational oral glucagon-like...
Semaglutide protects against diabetic retinopathy
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss,...
MBS for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo metabolic and bariatric surgery (MBS)...
Browse by tag
bottom of page